Public Health Impact of the Centers for Medicare and Medicaid Services Decision on Pass-Through Add-On Payments for Drug-Coated Balloons: A Call to Action.

Published

Journal Article (Review)

On Wednesday, November 1, 2017, the Centers for Medicare and Medicaid Services (CMS) made a public decision to end the transitional pass-through add-on payment for drug-coated balloons beginning January 1, 2018, without creating a new ambulatory payment classification rate for these devices. In this Viewpoint, the authors highlight the disconnect between the CMS's decision not to create a new ambulatory payment classification category for drug-coated balloons despite demonstrated clinical superiority. The authors believe this decision is more in line with a rigid fee-for-service payment system than a value-based system that encourages quality over quantity, and disadvantages both the elderly and the poor. They call on all who advocate for patients with peripheral artery disease to action, encouraging their engagement on CMS decisions regarding payment.

Full Text

Duke Authors

Cited Authors

  • Shishehbor, MH; Jaff, MR; Beckman, JA; Misra, S; Schneider, PA; Lookstein, R; Kashyap, VS; Aronow, HD; Jones, WS; White, CJ

Published Date

  • March 2018

Published In

Volume / Issue

  • 11 / 5

Start / End Page

  • 496 - 499

PubMed ID

  • 29519384

Pubmed Central ID

  • 29519384

Electronic International Standard Serial Number (EISSN)

  • 1876-7605

International Standard Serial Number (ISSN)

  • 1936-8798

Digital Object Identifier (DOI)

  • 10.1016/j.jcin.2018.01.233

Language

  • eng